Biomarker ID | 1403 |
PMID | 24737792 |
Year | 2014 |
Biomarker | miR-224 |
Biomarker Basis | RNA expression |
Biomolecule | miRNA |
Source | Tissue |
Subjects | Humans |
Regulation | Downregulated in PCa |
Odds Ratio/Hazard Ratio/Relative Risk | Cohort 1 : Univariate: HR: 0.59 (95% CI: 0.38-0.91), P-value= 0.018, C-Index= 0.67; Multivariate: HR= 0.83 (95% CI: 0.53-1.30), p-value= 0.405, C-Index= 0.86 |
Effect on Pathways | Pathways include: nucleoplasm; glutamatergic synapse; chromatin; nuclear chromosome; synapse |
Experiment | Biochemical recurrence Vs No Biochemical Recurrence |
Type of Biomarker | Prognostic |
Cohort | 30 nonmalignant and 30 prostate cancer tissue samples were used for this analysis |
Senstivity | 95.5% |
Specificity | 94.3% |
AUC | 0.98 |
Accuracy | NA |
Level Of Significance | p=0.001 |
Method Used | Training: Microarray; Validation: qRT-PCR |
Clinical | No |
Remarks | NA |
Clinical Trial Number | NA |
Degree Of Validity | Validated on independent patient dataset |
Technical Name | NA |